-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Treace Medical Concepts, Lowers Price Target to $3

Benzinga·12/18/2025 16:07:55
Listen to the news
Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $4 to $3.